EPS Bio Technology Corp. (TPEX:4183)

Market Cap	476.00M
Revenue (ttm)	451.08M
Net Income (ttm)	17.31M
Shares Out	23.80M
EPS (ttm)	0.73
PE Ratio	27.50
Forward PE	n/a
Dividend	0.67 (3.35%)
Ex-Dividend Date	Jun 24, 2024

Volume	5,000
Average Volume	2,689
Open	20.00
Previous Close	20.00
Day's Range	20.00 - 20.00
52-Week Range	18.70 - 30.60
Beta	0.34
RSI	43.54
Earnings Date	Mar 21, 2025

About EPS Bio Technology

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 109
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4183

Financial Performance

In 2024, EPS Bio Technology's revenue was 451.08 million, a decrease of -4.06% compared to the previous year's 470.17 million. Earnings were 17.31 million, a decrease of -17.54%.